Polivy Európai Unió - magyar - EMA (European Medicines Agency)

polivy

roche registration gmbh - polatuzumab vedotin - lymphoma, b-sejt - daganatellenes szerek - polivy kombinálva bendamustine, valamint rituximab kezelésére javallt, a felnőtt betegek relapszusos/refrakter diffúz nagy b-sejtes lymphoma (dlbcl), akik nem jelöltek haemopoetikus őssejt-transzplantációs. polivy in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone (r-chp) is indicated for the treatment of adult patients with previously untreated diffuse large b-cell lymphoma (dlbcl).

Dimethyl fumarate Neuraxpharm Európai Unió - magyar - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetil-fumarát - a sclerosis multiplex, a relapszáló-remittáló - immunszuppresszánsok - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Ebvallo Európai Unió - magyar - EMA (European Medicines Agency)

ebvallo

pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.